Antimicrobial resistance: paradox, actions and economics

The Journal of Antimicrobial Chemotherapy
Richard Wise

Abstract

The threat from antimicrobial-resistant organisms is accumulating and accelerating. One strand of the action that an adequate response to this threat demands is good clinical governance through management and audit of antimicrobial prescribing in hospitals. This is the subject of another article in this issue of the Journal, which describes the guidelines developed by the Scottish Medicines Consortium and Scottish Health Executive to tackle this problem. However, the problems posed by resistant organisms are wider still. In a period of increased threat, innovation (new drugs and technologies) seems to be in decline. There are grounds for serious concern that the current economic model is not capable of responding adequately. Governments need to acknowledge and address this fact. Patient outcomes will suffer increasingly if governments do not act to change the status quo.

Citations

Jan 29, 2009·International Journal of Biological Sciences·San TinMeena K Sakharkar
Jun 12, 2008·Wiener klinische Wochenschrift·Franz AllerbergerUNKNOWN ABS International
Jan 29, 2008·The Lancet Infectious Diseases·Ian ChopraPatrice Courvalin
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F Allerberger, H Mittermayer
Dec 17, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G L French
Apr 1, 2008·Bioorganic & Medicinal Chemistry Letters·Sharaf Nawaz KhanHong-Seok Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.